Platelet polymorphisms: Frequency distribution and association with coronary artery disease in an Indian population

Platelets

Volumn 22, Issue 2, 2011, Pages 85-91

  Ashavaid, Tester F ^a   Todur, Seema P ^a   Kondkar, Altaf A ^a   Nair, K G ^a   Shalia, Kavita K ^a   Dalal, Jamshed J ^a   Rajani, Rajesh ^a   Ponde, Chandrashekhar K ^a  

^a P D HINDUJA NATIONAL HOSPITAL   (India)

Author keywords

CAD; fibrinolytic; polymorphism; Thrombotic

Indexed keywords

ENDONUCLEASE; FIBRINOGEN; FIBRINOGEN ALPHA; FIBRINOGEN BETA; FIBRINOGEN RECEPTOR; GLYCOPROTEIN; GLYCOPROTEIN IB IX V; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 2;

ADULT; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; ENZYME DEGRADATION; FEMALE; FIBRINOLYSIS; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEMOSTASIS; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; THROMBOCYTE; THROMBOSIS; UNSTABLE ANGINA PECTORIS;

ADULT; AGED; ALLELES; BLOOD PLATELETS; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; FIBRINOGEN; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET MEMBRANE GLYCOPROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

ANGINA;

EID: 79751480172     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2010.522275     Document Type: Article

References (37)

1. Enas EA. Coronary artery disease epidemic in Indians: A cause for alarm and call for action. J Indian Med Assoc 2000;98:694-702. (Pubitemid 33708179)
2. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-126. (Pubitemid 29054847)
3. Voetsch B, Loscalzo J. Genetic determinants of arterial thrombosis. Arterioscler Thromb Vasc Biol 2004;24: 216-229. (Pubitemid 38197572)
4. Meisel C, Lopez JA, Stangl K. Role of platelet glycoprotein polymorphisms in cardiovascular diseases. Naunyn- Schmiedeberg's Arch Pharmacol 2004;369:38-54. (Pubitemid 38161222)
5. Miller SA, Dykes DD, Polesky HF. A simple salting-out procedure for extracting DNA from human nucleate cell. Nucleic Acids Res 1988;16:1219.
6. Anderson JF, King GJ, Bair TL, Elmer SP, Muhlestein JB, Habashi J, Carlquist JF. Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease. J Am Coll Cardiol 1999;33:727-733.
7. Murata M, Matsubara Y, Kawano K, Zama T, Aoki N, Yoshino H, Watanabe G, Ishikawa K, Ikeda Y. Coronary artery disease and polymorphisms in a receptor mediating shear stress-dependent platelet activation. Circulation 1997; 96:3281-3286. (Pubitemid 27513395)
8. Thomas A, Lamlum H, Humphries S, Green F. Linkage disequilibrium across the fibrinogen locus as shown by five genetic polymorphisms, G/A-455 (HaeIII), C/T-148 (hindIII/ AluI), T/G+1689 (AvaII), and BclI (B-fibrinogen) and TaqI (a-fibrinogen), and their detection by PCR. Human Mutat 1994;3:79-81.
9. Tybjaerg-Hansen A, Agerholm-Larsen B, Humphries SE, Abildgaard S, Schnohr P, Nordestgaard BG. A common mutation (G-455→A) in the b-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9127 individuals based on the Copenhagen City Heart Study. J Clin Invest 1997;99:3034-3039.
10. Blake GJ, Schmitz C, Lindpaintner K, Ridker PM. Mutation in the promoter region of theβ-fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosis. Eur Heart J 2001;22:2262-2266. (Pubitemid 34000981)
11. Baumann RE, Henschen AH. Human fibrinogen polymorphic site analysis by restriction endonuclease digestion and allelespecific polymerase chain reaction amplification: Identification of polymorphisms at positions Aα312 and Bβ448. Blood 1993;82:2117-2124. (Pubitemid 23293995)
12. Santoso S, Kunicki TJ, Kroll H, Haberbosch W, Gardemann A. Association of the platelet glycoprotein Ia C807T gene polymorphism with nonfatal myocardial infarction in younger patients. Blood 1999;93:2449-2453. (Pubitemid 29181174)
13. Zhan M, Zhou Y, Han Z. Plasminogen activator inhibitor-1 4G/5G gene polymorphism in patients with myocardial or cerebrovascular infarction in Tianjin, China. Chinese Med J 2003;116:1707-1710. (Pubitemid 38008245)
14. Kulkarni B, Mohany D, Ghosh K, Pawar A, Khare A. Frequency distribution of antigens in the human platelet antigen-1system in the western Indian population. Transfusion 2002;42:317-320.
15. Ridker PM, Hennekens CH, Schmitz C, Stampfer MJ, Lindpaintner K. PL(A1/A2) polymorphism of platelet glycoprotein IIIa and the risks of myocardial infarction, stroke, and venous thrombosis. Lancet 1997;349:385-388. (Pubitemid 27077666)
16. Gonzalez-Conejero R, Lozano ML, Rivera J, Corral J, Iniesta JA, Moraleda JM, Vicente V. Polymorphisms of platelet membrane glycoprotein Ib associated with arterial thrombotic disease. Blood 1998;92:2771-2776. (Pubitemid 28469091)
17. Dinauer DM, Friedman KD, Hessner MJ. Allelic distribution of the glycoprotein Ia (α2-integrin) C807T/G873A dimorphisms among Caucasian venous thrombosis patients and six racial groups. Br J Hemat 1999;107:563-565.
18. Humphries SE, Cook M, Dubowitz M, Striling Y, Meade TW. Role of genetic variation at the fibrinogen locus in determination of fibrinogen concentrations. Lancet 1987;i:1452.
19. Liu Y, saha N, Heng CK, Hong S, Low PS. Fibrinogen genotypes (a and b) are associated with plasma fibrinogen levels in Chinese. JMG 2001;38:e31.
20. Kain K, Blaxill JM, Catto AJ, Grant PJ, Carter AM. Increased fibrinogen levels among South Asians versus Whites in the United Kingdom are not explained by common polymorphisms. Am J Epidemiol 2002;156:174-179. (Pubitemid 34755956)
21. Yang Z, Li F, Liu G, Cai W, Ling G. The study of betafibrinogen gene - 455 G/A, - 148 C/T, 448 G/A polymorphisms and their association with plasma fibrinogen levels. Zhonghua Xue Ye Xue Za Zhi 2000;21:463-465.
22. Zito F, Castelnuovo AD, Amore C, D'Orazio A, Donati MB, Iacoviello L. BclI polymorphism in the fibrinogenβ-chain gene is associated with the risk of familial myocardial infarction by increasing plasma fibrinogen levels. A case- control study in a sample of GISSI-2 patients. Arterioscler Thromb Vasc Biol 1997;17:3489-3494. (Pubitemid 28028560)
23. Carter AM, Ossei-Gerning N, Wilson IJ, Grant PJ. Association of the platelet PIA polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bb448 with myocardial infarction and extent of coronary artery disease. Circulation 1997;96:1424-1431. (Pubitemid 27375332)
24. Ni Y, Hu D, Yu H, Li C, Liu W, Wang H, Li L. Association of genetic polymorphisms in the fibrinogen and platelet glycoprotein genes with unstable angina in Chinese patients. Clin Cardiol 2004;27:455-458.
25. Carter AM, Catto AJ, Kohler HP, Ariens RAS, Stickland MH, Grant PJ.α-fibrinogen Thr312Ala polymorphism and venous thromboembolism. Blood 2000;96:1177-1179. (Pubitemid 30616891)
26. de Maat MP, Kastelein JJ, Jukema JW, Zwinderman AH, Jansen H, Groenemeier B, Bruschke AV, Kluft C. -455G/A polymorphism of the beta-fibrinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men: Proposed role for an acute-phase reaction pattern of fibrinogen. REGRESS group. Arterioscler Thromb Vasc Biol 1998;18:265-271. (Pubitemid 28277604)
27. Green F, Hamsten A, Blombäck M, Humphries S. The role of b-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden. Thromb Haemost 1993;70:915-920. (Pubitemid 24008799)
28. Scarabin P, Bara L, Ricard S, Poirier O, Cambou JP, Arveiler D, Luc G, Evans AE, Samama MM, Cambien F. Genetic variation at the b-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction: The ECTIM study. Arterioscler Thromb 1993;13:886-891. (Pubitemid 23164692)
29. van der Bom, de Knijff P, Haverkate F et al. Tissue plasminogen activator and risk of myocardial infarction Circulation 1997;95:2623-2627. (Pubitemid 27255490)
30. Ridker PM, Baker MT, Hennekens CH, Stampfer MJ, Vaughan DE. Alu-repeat polymorphism in the gene coding for tissue-type plasminogen activator (t-PA) and risks of myocardial infarction among middle-aged men. Arterioscler Thromb Vasc Biol 1997;17:1687-1690. (Pubitemid 27423988)
31. Makalowski W, Mitchell GA, Labuda D. Alu sequences in the coding regions of mRNA: A source of protein variability. Trends Genet 1994;10:188-193. (Pubitemid 24162752)
32. Fu L, Jin H, Song K, Zhang C, Shen J, Huang Y. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction. Chin Med J 2001;114:266-269. (Pubitemid 33611214)
33. Ranjith N, Pedgoraro RJ, Rom L. Hemostatic gene polymorphisms in young Indian Asian subjects with acute myocardial infarction. Med Sci Monit 2003;9:CR417-421. (Pubitemid 37305251)
34. Ye Z, Liu EH, Higgins JP, Keavney BD, Lowe GD, Collins R, Danesh J. Seven haemostatic gene polymorphisms in coronary disease: Meta-analysis of 66,155 cases and 91,307 controls. Lancet 2006;367:651-658. (Pubitemid 43289155)
35. Ashavaid TF, Shalia KK, Kondkar AK, Todur SP, Nair KG, Nair SR. Gene polymorphism and coronary risk factors in Indian population. Clin Chem Lab Med 2002;40:975-985. (Pubitemid 35356014)
36. Ashavaid TF, Shalia KK, Dalal J. ACE and AT1R gene polymorphisms and hypertension in Indian population. J Clin Lab Anal 2000;14:230-237.
37. Nair KG, Nair SR, Ashavaid TF, Dalal JJ, Eghlim FF. Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population. J Assoc Phys Ind 2002;50:9-15.